A drug's life cycle and communication of safety issues

被引:0
|
作者
Mol, Peter [1 ,2 ]
de Vries, Jonie [1 ]
Straus, Sabine [2 ]
de Graeff, Pieter [1 ,2 ]
Haaijer-Ruskamp, Flora [1 ]
机构
[1] Univ Med Ctr, Groningen, Netherlands
[2] Dutch Med Evaluat Board, The Hague, Netherlands
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
468
引用
收藏
页码:S205 / S206
页数:2
相关论文
共 50 条
  • [31] Remifentanil - Safety issues with a new opioid drug
    Hug, CC
    JOURNAL OF CLINICAL MONITORING, 1997, 13 (03): : 203 - 204
  • [33] Nanotechnology in Drug Delivery: Safety and Toxicity Issues
    Jain, Keerti
    Mehra, Neelesh Kumar
    Jain, Narendra K.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (29) : 4252 - 4261
  • [34] Communication about Prognosis and End of Life Issues
    Butow, Phyllis
    Tattersall, Martin
    PSYCHO-ONCOLOGY, 2014, 23 : 5 - 6
  • [35] Drug life-cycle technologies
    Fleming, E
    Ma, P
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) : 751 - 752
  • [36] Drug life-cycle technologies
    Edd Fleming
    Philip Ma
    Nature Reviews Drug Discovery, 2002, 1 : 751 - 752
  • [37] ISSUES AND RECENT TRENDS IN VEHICLE SAFETY COMMUNICATION SYSTEMS
    Tsugawa, Sadayuki
    IATSS RESEARCH, 2005, 29 (01) : 7 - 15
  • [38] Water-Based Safety Issues and Communication Opportunities
    Tsakakis, Elena
    Schneider, Ingrid
    JOURNAL OF PARK AND RECREATION ADMINISTRATION, 2021, 39 (04) : 161 - 169
  • [39] Analysis of the factors influencing the spontaneous reporting frequency of drug safety issues addressed in the FDA's drug safety communications, using FAERS data
    Ishiguro C.
    Hinomura Y.
    Uemura K.
    Matsuda T.
    Pharmaceutical Medicine, 2014, 28 (1) : 7 - 19
  • [40] Heart failure treatments - Issues of safety versus issues of quality of life
    Feenstra, J
    Lubsen, J
    Grobbee, DE
    Stricker, BHC
    DRUG SAFETY, 1999, 20 (01) : 1 - 7